Skip to main content
. 2022 Apr 11;66(5):e01896-21. doi: 10.1128/aac.01896-21

FIG 2.

FIG 2

Expression of VapC2 and VapC21 leads to growth inhibition. (A and B) Growth profile of M. smegmatis cells harboring anhydrotetracycline (ATC)-inducible plasmid expressing either VapC2 or VapC21 with (+ATC) or without (-ATC) the inducer. (C and D) Growth profile of M. tuberculosis cells harboring the pristinamycin (PTM)-inducible plasmid expressing either VapC2 or VapC21 with (+PTM) or without (-PTM) inducer.